Lei Dong Selected Research

Particle Accelerators

9/2020	Initial Clinical Experience Treating Patients With Lung Cancer on a 6MV-Flattening-Filter-Free O-Ring Linear Accelerator.
9/2020	Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear accelerator.
9/2020	Initial Clinical Experience Treating Patients With Gynecologic Cancers on a 6MV Flattening Filter Free O-Ring Linear Accelerator.
8/2020	Initial Evaluation of a Novel Cone-Beam CT-Based Semi-Automated Online Adaptive Radiotherapy System for Head and Neck Cancer Treatment - A Timing and Automation Quality Study.
10/2019	Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator.
10/2009	Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model.
5/2008	Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy.
7/2004	Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Dong Research Topics

Disease

176	Neoplasms (Cancer) 10/2022 - 07/2004
37	Prostatic Neoplasms (Prostate Cancer) 12/2013 - 06/2002
28	Stomach Neoplasms (Stomach Cancer) 03/2022 - 12/2004
24	Fibrosis (Cirrhosis) 01/2022 - 10/2002
23	Inflammation (Inflammations) 09/2021 - 03/2009
21	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2005
19	Liver Cirrhosis (Hepatic Cirrhosis) 04/2021 - 10/2002
14	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2005
13	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2006
13	Colitis 01/2021 - 07/2009
13	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2008
13	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 07/2004
12	Carcinogenesis 01/2022 - 12/2012
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 03/2004
11	Infections 03/2022 - 05/2003
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 10/2015
10	Adenocarcinoma 12/2019 - 12/2003
9	Sepsis (Septicemia) 01/2022 - 03/2012
9	Body Weight (Weight, Body) 01/2021 - 09/2008
9	Carcinoma (Carcinomatosis) 01/2020 - 08/2002
8	Hemorrhage 11/2017 - 06/2004
8	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2014 - 09/2007
7	Glioma (Gliomas) 10/2022 - 01/2015
7	Pneumonia (Pneumonitis) 05/2022 - 11/2011
7	Non-alcoholic Fatty Liver Disease 01/2021 - 04/2008
7	Diarrhea 01/2021 - 09/2007
6	Liver Diseases (Liver Disease) 11/2022 - 03/2009
6	Hypoxia (Hypoxemia) 06/2022 - 09/2016
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 04/2012
6	Hypertension (High Blood Pressure) 01/2021 - 04/2010
6	Wounds and Injuries (Trauma) 10/2019 - 07/2010
6	Osteolysis 01/2017 - 08/2008
5	Necrosis 11/2022 - 04/2010
5	Mastitis 01/2022 - 11/2017
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2020
5	Cardiotoxicity 01/2022 - 08/2010
5	Brain Neoplasms (Brain Tumor) 01/2022 - 08/2013
5	Colonic Neoplasms (Colon Cancer) 06/2021 - 06/2014
5	Leukemia 01/2021 - 01/2015
5	Constipation 09/2013 - 09/2007
4	Disease Progression 02/2021 - 01/2008
4	Weight Loss (Weight Reduction) 10/2020 - 07/2004
4	Hypersensitivity (Allergy) 08/2020 - 03/2011
4	Ulcerative Colitis 01/2019 - 07/2009

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2007
27	Pharmaceutical PreparationsIBA 06/2022 - 04/2009
22	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2012
19	Messenger RNA (mRNA)IBA 06/2021 - 01/2004
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2008
16	Protons (Proton)IBA 01/2022 - 03/2007
15	Biological ProductsIBA 01/2022 - 09/2005
15	Therapeutic UsesIBA 01/2018 - 07/2008
14	CytokinesIBA 01/2018 - 09/2008
11	6-methyladenineIBA 01/2022 - 01/2017
11	CollagenIBA 10/2019 - 01/2011
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2009
9	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 08/2013
9	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
8	Long Noncoding RNAIBA 01/2022 - 12/2014
8	CateninsIBA 01/2021 - 04/2014
8	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2015 - 07/2008
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 04/2009
7	Small Interfering RNA (siRNA)IBA 01/2019 - 12/2012
6	CholesterolIBA 01/2022 - 06/2005
6	LipidsIBA 09/2021 - 07/2011
6	Chlorogenic AcidIBA 01/2021 - 11/2009
6	Antisense OligonucleotidesIBA 01/2021 - 08/2008
6	Sulfonic AcidsIBA 09/2018 - 04/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 08/2008
5	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 04/2014
5	3,3'-diindolylmethane (diindolylmethane)IBA 01/2021 - 03/2010
5	TOR Serine-Threonine KinasesIBA 01/2020 - 04/2013
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
5	N-methyladenosineIBA 01/2020 - 01/2017
5	Indicators and Reagents (Reagents)IBA 10/2015 - 01/2013
5	Hormones (Hormone)IBA 10/2013 - 08/2003
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2008 - 08/2003
4	LigandsIBA 12/2021 - 06/2016
4	Peptides (Polypeptides)IBA 04/2021 - 12/2004
4	CreatinineIBA 10/2020 - 01/2018
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 08/2014
4	LipopolysaccharidesIBA 01/2019 - 03/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 06/2007
4	sym-trinitrobenzeneIBA 01/2018 - 04/2010
4	HydrogelsIBA 01/2018 - 09/2009

Therapy/Procedure

85	Radiotherapy 04/2022 - 08/2003
59	Therapeutics 06/2022 - 08/2003
19	Proton Therapy 01/2022 - 02/2007
14	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2020 - 06/2002
13	Drug Therapy (Chemotherapy) 06/2022 - 10/2009
12	Immunotherapy 01/2021 - 03/2012
8	Particle Accelerators 09/2020 - 07/2004
7	Conformal Radiotherapy 11/2010 - 12/2002
5	Microbubbles 06/2022 - 02/2018
5	Transplantation 01/2018 - 08/2008
5	Hematopoietic Stem Cell Transplantation 10/2017 - 12/2011
4	Ligation 01/2022 - 05/2003
4	Intraperitoneal Injections 01/2021 - 06/2005
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2020 - 02/2008
4	Catheters 09/2019 - 02/2009